Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
American Journal of Botany
|
July 16, 1999
The architecture of Mourera fluviatilis (Podostemaceae): developmental morphology of inflorescences, flowers, and seedlings
R Rutishauser, M Grubert
Biophysical Chemistry
|
September 1, 1981
A comparative calorimetric study on tRNA unfolding
F J Schott, M Grubert, W Wangler, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
February 11, 2009
Plasma and cellular pharmacokinetics of doxorubicin after intravenous infusion of Caelyx/Doxil in patients with hematological tumors
H Richly, M Grubert, M E Scheulen, et al.
Phytochemistry
|
December 1, 1994
Bioactive chromenes from Rhyncholacis penicillata
G Burkhardt, H Becker, M Grubert, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2003
The influence of liver metastases on the pharmacokinetics of doxorubicin---a population-based pharmacokinetic project of the CESAR-APOH
H J Müller, R E Port, M Grubert, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 31, 2002
The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin--a population based pharmacokinetic study of CESAR-APOH. Central European Society for Anticancer Drug Research. Working Group for Pharmacology in Oncology and Hematology
H J Müller, M Grubert, R Hilger, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 24, 2005
Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil
R A Hilger, H Richly, M Grubert, et al.
Medical Hypotheses
|
January 6, 2020
Does SEN-V and other non-A-E hepatotropic viruses contribute to the development and progression of non-alcoholic fatty liver disease?
M Grubert Van Iderstine, C Osiowy, C Rumbolt, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
February 11, 2009
Pharmacokinetics of sorafenib in patients with renal impairment undergoing hemodialysis
R A Hilger, H Richly, M Grubert, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
March 10, 2005
Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake
Jaime M Grubert, Margaret Lautz, D Brooks Lacy, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
American Journal of Botany
|
July 16, 1999
The architecture of Mourera fluviatilis (Podostemaceae): developmental morphology of inflorescences, flowers, and seedlings
R Rutishauser, M Grubert
Biophysical Chemistry
|
September 1, 1981
A comparative calorimetric study on tRNA unfolding
F J Schott, M Grubert, W Wangler, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
February 11, 2009
Plasma and cellular pharmacokinetics of doxorubicin after intravenous infusion of Caelyx/Doxil in patients with hematological tumors
H Richly, M Grubert, M E Scheulen, et al.
Phytochemistry
|
December 1, 1994
Bioactive chromenes from Rhyncholacis penicillata
G Burkhardt, H Becker, M Grubert, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2003
The influence of liver metastases on the pharmacokinetics of doxorubicin---a population-based pharmacokinetic project of the CESAR-APOH
H J Müller, R E Port, M Grubert, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 31, 2002
The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin--a population based pharmacokinetic study of CESAR-APOH. Central European Society for Anticancer Drug Research. Working Group for Pharmacology in Oncology and Hematology
H J Müller, M Grubert, R Hilger, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 24, 2005
Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil
R A Hilger, H Richly, M Grubert, et al.
Medical Hypotheses
|
January 6, 2020
Does SEN-V and other non-A-E hepatotropic viruses contribute to the development and progression of non-alcoholic fatty liver disease?
M Grubert Van Iderstine, C Osiowy, C Rumbolt, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
February 11, 2009
Pharmacokinetics of sorafenib in patients with renal impairment undergoing hemodialysis
R A Hilger, H Richly, M Grubert, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
March 10, 2005
Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake
Jaime M Grubert, Margaret Lautz, D Brooks Lacy, et al.
Page
of 2